EyePoint Pharmaceuticals Inc (EYPT)
7.27
-0.06
(-0.82%)
USD |
NASDAQ |
Dec 26, 11:14
EyePoint Pharmaceuticals Cash from Investing (Quarterly): 16.20M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cassava Sciences Inc | -0.017M |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Adverum Biotechnologies Inc | -13.35M |
| Regenxbio Inc | 50.26M |
| Editas Medicine Inc | 83.98M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -39.03M |
| Cash from Financing (Quarterly) | 11.89M |
| Free Cash Flow | -118.04M |
| Free Cash Flow Per Share (Quarterly) | -0.7457 |
| Free Cash Flow to Equity (Quarterly) | -40.60M |
| Free Cash Flow Yield | -32.03% |